Search results
Showing 1891 to 1905 of 8887 results
In development Reference number: GID-QS10196 Expected publication date: 28 January 2027
We are listening to your views on this Technology appraisal guidance. Comments close 14 April 2026.
We are listening to your views on this Technology appraisal guidance. Comments close 7 April 2026.
In development Reference number: GID-TA11516 Expected publication date: 06 May 2027
In development Reference number: GID-TA11422 Expected publication date: 18 November 2026
Setmelanotide for treating acquired hypothalamic obesity in people 4 years and over [ID6542]
In development Reference number: GID-TA11525 Expected publication date: 10 February 2027
In development Reference number: GID-TA11488 Expected publication date: 15 July 2026
In development Reference number: GID-TA10326 Expected publication date: TBC
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps [ID6379]
In development Reference number: GID-TA11429 Expected publication date: 09 September 2026
Tolebrutinib for treating non-relapsing secondary progressive multiple sclerosis [ID6351]
In development Reference number: GID-TA11333 Expected publication date: TBC
In development Reference number: GID-TA11693 Expected publication date: TBC
Bentracimab for reversing the antiplatelet activity of ticagrelor [ID6344]
Awaiting development Reference number: GID-TA11354 Expected publication date: TBC
Awaiting development Reference number: GID-TA11717 Expected publication date: TBC
Awaiting development Reference number: GID-TA11783 Expected publication date: TBC
Deucravacitinib for treating active psoriatic arthritis [ID6561]
Awaiting development Reference number: GID-TA11510 Expected publication date: TBC